TANDEM DIABETES CARE INC cotiza a 16.65 USD y tiene una capitalización bursátil de $1.2B. En los últimos 12 meses ha facturado $1.0B con un margen de flujo de caja libre del -2.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells sin…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.31 | $-0.30 | $-0.01 |
| Estimado | $-0.24 | $-0.32 | $-0.44 | $-0.09 |
| Sorpresa | — | +3.1% | +31.8% | +88.9% |
| Métrica | TNDM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 53.8% | 57.0% | -3.2% |
| Operating Margin | -18.4% | -38.6% | +20.2% |
| Net Margin | -20.2% | -33.6% | +13.4% |
| FCF Margin | -2.9% | -13.9% | +10.9% |
| ROE | -131.9% | -40.4% | -91.5% |
| ROA | -23.2% | -32.0% | +8.8% |
| Current Ratio | 2.55 | 2.84 | -0.29 |
| Debt / Equity | 2.00 | 0.28 | +1.72 |